Author:
Venkata Ratnam Kamsala,Md. Bhakshu Lepakshi,Venkata Raju Rudraraju Reddy
Reference70 articles.
1. Arias E, Alés E, Gabilan NH, Cano-Abad MF, Villarroya M, García AG, López MG (2004) Galantamine prevents apoptosis induced by β-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology 46:103–114
2. Ascherio A, Chen H (2003) Caffeinated clues from epidemiology of Parkinson’s disease. Neurology 61:S51–S54
3. Ascherio A, Zhang SM, Hernan MA (2001) Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women. Ann Neurol 50:56–63
4. Ascherio A, Weisskopf MG, O'Reilly EJ (2004) Coffee consumption, gender, and Parkinson’s disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 160:977–984
5. Banu MR, Ibrahim M, Prabu K, Rajasankar S (2019) Neuroprotective efficacy of withaferin A on aging mediated oxidative stress in striatum and Substantia nigra of wistar albino rat. Drug Invent Today 12:425–431